Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

5.85USD
23 Jul 2014
Price Change (% chg)

$-0.03 (-0.51%)
Prev Close
$5.88
Open
$5.62
Day's High
$5.90
Day's Low
$5.62
Volume
2,517
Avg. Vol
4,869
52-wk High
$9.44
52-wk Low
$3.01

IMMY.OQ

Chart for IMMY.OQ

About

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company’s Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company’s lead pain product,... (more)
No analyst recommendations are available for IMMY.OQ.

Overall

Beta: -1.26
Market Cap (Mil.): $54.53
Shares Outstanding (Mil.): 9.10
Dividend: --
Yield (%): --

Financials

  IMMY.OQ Industry Sector
P/E (TTM): -- 102.18 35.85
EPS (TTM): -0.95 -- --
ROI: -52.82 -0.10 18.25
ROE: -52.82 -0.88 19.12
Search Stocks

Competitors

  Price Change
Eli Lilly and Co (LLY.N) $64.25 +0.53
Sanofi SA (SASY.PA) €76.94 +0.01
Bayer AG (BAYGn.DE) €100.25 -0.15
Bayer AG (BAYE.F) -- --
Roche Holding Ltd. (ROG.VX) CHF270.20 +3.70
Merck & Co., Inc. (MRK.N) $58.11 -0.32
Novartis AG (NOVN.VX) CHF80.45 +0.25

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: TheStreet.com Ratings
$10.00
Provider: TheStreet.com Ratings
$10.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks